NCT06407401: Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
- State
- Not started
- Phase
- Phase 3
- People
- 399 planned
- Started
- Dec 2024
- Primary completion
- 18 Apr 2028
- Arms
- Experimental arm SoC with duloxetine
- Results
- None posted
- 9 May 2024: Trial registered